Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1147/week)
    • Manufacturing(552/week)
    • Energy(450/week)
    • Technology(1058/week)
    • Other Manufacturing(345/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Cutaneous conditions

Oct 11, 2018
Sebacia EU Real-World Results Demonstrate an Average 79% Improvement in Acne at 6 Months
Sep 14, 2018
Experts Call for Improved Identification of 'High Burden' Rosacea Patients in Everyday Practice
Aug 29, 2018
FDA Accepts Resubmission Of New Drug Application For Duobrii(TM)1 (Halobetasol Propionate And Tazarotene) Lotion
Aug 15, 2018
Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII(TM) (halobetasol propionate and tazarotene) Lotion
Aug 08, 2018
Restylane Lyft for Hand Rejuvenation Now Available at Maryland Dermatology Laser Skin & Vein Institute
Jul 31, 2018
BioPharmX Receives IRB Approval to Initiate Phase 2 Trial of BPX-04 for the Treatment of Rosacea
Jul 16, 2018
Scar Treatment Market to Become Worth US$ 29,592.1 Mn by 2026, Says TMR
Jun 27, 2018
AcneFree & The American Acne & Rosacea Society Seek To Help A New Generation Of Acne Sufferers
May 24, 2018
Realm Therapeutics Completes Enrollment in Phase 2 Study of PR022 for Atopic Dermatitis
May 24, 2018
BioPharmX Studies Show Hydrophilic Topical Minocycline Gels May Be the Preferred Treatment Option for Acne, Rosacea Patients
May 21, 2018
Realm Therapeutics Presents Data Highlighting its Proprietary Immunomodulatory Technology's Potential in Acne and Psoriasis at IID 2018
May 07, 2018
Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne
Jan 12, 2018
BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This Month
Dec 13, 2017
Hovione Announces Enrollment of First Patient in MARS, a Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel
Oct 18, 2017
BioPharmX to Present at Re-entering Antibacterial Discovery and Development Summit 2017
Sep 27, 2017
Fotona Receives FDA Clearance for New StarWalker® MaQX Ultra Performance Q-Switched System for Treating Tattoos, Pigmented and Vascular Lesions, Acne Scars & Hair Reduction
Sep 12, 2017
BioPharmX Announces Preliminary Data from Rosacea Feasibility Study
Jul 27, 2017
Summer AAD Panel to Discuss BPX-01 for Acne and Rosacea
  • ‹‹
  • Page 2
  •  

Latest News

Jul 19, 2025

Xcel Energy Announces Portfolio of New Power Projects to Meet Growing Demand in Texas and New Mexico

Jul 19, 2025

nVent Electric plc to Report Second Quarter 2025 Financial Results on August 1

Jul 19, 2025

ParkOhio Announces Quarterly Dividend

Jul 19, 2025

Tomarco Contractor Specialties/ISAT Total Support, Win Innovation Award at 2025 ACG Los Angeles Awards Gala

Jul 19, 2025

Ostia Sciences Inc. Completes $1.46M Seed Round to Develop Microbiome Therapeutics Platform.

Jul 19, 2025

Supplier And Contract Manufacturer Management Course | Leverage Risk Assessment Techniques to Optimize...

Jul 19, 2025

Oshkosh Corporation to Announce Second Quarter 2025 Earnings on August 1, 2025

Jul 18, 2025

Small Satellites Market Research and Technology Forecast Report 2025-2033 | Investment Opportunities,...

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia